Panoptive
The continuous oversight engine for clinical trials
Based based in San Francisco, CA, USA, Panoptive works in b2b.
Profile
We turn unstructured monitoring data - monitoring visit reports, EDC data - into structured deviation, safety, and quality findings for human review. Panoptive generates an audit-ready oversight trail as a natural byproduct.
The platform aggregates findings and identifies systemic patterns across sites and subjects before they compound, and tracks every finding through decision, follow-up, and resolution.
Its activity falls under b2b; the profile below is assembled from public directory data.
San Francisco, CA, USA is where the company is located.
Directory data places it at the Summer 2025 stage.
Recorded headcount: 2 employees.
Directory analysis
Panoptive offers a continuous oversight engine for clinical trials, converting unstructured monitoring data into structured deviation, safety, and quality findings. The platform generates audit‑ready oversight trails and aggregates findings to identify systemic patterns across sites and subjects, tracking each finding through decision, follow‑up, and resolution.
Positioning: Panoptive positions itself as a data‑centric compliance tool within the clinical trial monitoring space, targeting sponsors and CROs that need automated oversight. Its small team and early stage suggest a niche focus on improving monitoring efficiency.
Note: Panoptive is a San Francisco‑based B2B startup focused on clinical trial oversight.
Auto-generated directory analysis from public data · updated 10 Oct 2026. Informational only, not investment advice.
| Sector | B2B |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 2 |
| Stage | Summer 2025 |
Website: www.panoptive.com
Browse related
Create a free account